[1]
Parr J.R., Andrew M.J., Finnis M., et al.: Jayawant, How common is
childhood myasthenia? The UK incidence and prevalence of autoimmune
and congenital myasthenia. Arch Dis Child 2014; 99: 539–542.
[2]
Engel A.G., Shen X.M., Selcen D., et al.: Congenital myasthenic syndromes:
pathogenesis, diagnosis, and treatment. The Lancet. Neurology
2015; 14: 420–434.
[3]
Lorenzoni P.J., Scola R.H., Kay C.S., et al.: Congenital myasthenic syndrome:
a brief review, Pediatric neurology 2012; 46: 141–148.
[4]
Beeson D., den Dunnen J.: Cholinergic receptor, nicotinic, epsilon
(CHRNE). Leiden Muscular Dystrophy pages. Adress: http://www.dmd.
nl/, (accessed 26–06–2017.).
[5]
Landoure G., Knight M.A., Stanescu H., et al.: A candidate gene for autoimmune
myasthenia gravis. Neurology 2012; 79: 342–347.
[6]
Pirskanen R., Genetic aspects in myasthenia gravis. A family study of
264 Finnish patients. Acta Neurol Scand 1977; 56 (5): 365–388.
[7]
Provenzano C., Arancio O., Evoli A., et al.: Familial autoimmune myasthenia
gravis with different pathogenetic antibodies. J Neurol Neurosurg
Psychiatry 1988; 51 (9): 1228–1230.
[8]
Rodriguez Cruz P.M., Palace J., Beeson D.: Inherited disorders of the neuromuscular
junction: an update. Journal of neurology 2014; 261 (11):
2234–2243.
[9]
Burke G., Cossins J., Maxwell S., et al.: Distinct phenotypes of congenital
acetylcholine receptor deficiency. Neuromuscular disorders : NMD
2004; 14 (6): 356–364.
[10]
Ashraf V.V., Taly A.B., Veerendrakumar M., et al.: Myasthenia gravis in
children: a longitudinal study. Acta Neurol Scand 2006; 114 (2): 119–123.
[11]
Evoli A., Batocchi A.P., Bartoccioni E., et al.: Juvenile myasthenia gravis
with prepubertal onset. Neuromuscular disorders : NMD 1998; 8 (8):
561–567.
[12]
Santos E., Moreira I., Coutinho E., et al.: Congenital myasthenic syndrome
due to mutation in CHRNE gene with clinical worsening and thymic
hyperplasia attributed to association with autoimmune-myasthenia
gravis. Neuromuscular disorders: NMD 2015; 25 (12): 928–931.
[13]
Croxen R., Vincent A., Newsom-Davis J., et al.: Myasthenia gravis in
a woman with congenital AChR deficiency due to epsilon-subunit mutations.
Neurology 2002; 58: 1563–1565.
[14]
Heckmann J.M., Morrison K.E., Emeryk-Szajewska B., et.al.: Human
muscle acetylcholine receptor alpha-subunit gene (CHRNA1) association
with autoimmune myasthenia gravis in black, mixed-ancestry and
Caucasian subjects. J Autoimmun 1996; 9: 175–180.
[15]
Das A.S., Agamanolis D.P., Cohen B.H.: Use of next-generation sequencing
as a diagnostic tool for congenital myasthenic syndrome. Pediatric
neurology 2014; 51: 717–720.